ArticleCancer immunology research2014

Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.

Te-Chia Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.